drugset / Trial / NCT06068543
Reducing Frailty for Older Cancer Survivors Using Supplements II
RandomizedParallel-groupTriple-blindSupportive care
Summary
This study is a two-arm placebo controlled randomized clinical trial, to assess the effect of a 12-week EGCG intervention on physical frailty compared to placebo in pre-frail older cancer survivors.
Timeline
- Start
- 2024-10-25
- Primary completion
- 2030-01-01
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epigallocatechin gallate | Small molecule | 800 mg | — |
Indications
No indication recorded.